Portfolio Overview

LifeArc Demo

Which project mix best advances LifeArc's MND validation and early-detection goals in the current round?

Hub Decision Context

This demo is scoped to one hub manager and one goal-setting context.

Hub Goal

Advance earlier MND intervention by balancing target validation with earlier detection capability.

Target Milestones

Validated MND target package / Biomarker panel and GP risk-score prototype

Constraint

Committee asks total £315,000 against a working round budget of £180,000.

Funding Gap

£135,000

Amount requested beyond the available budget

Target Milestones

3

Named milestones this hub is trying to reach

Budget

£180,000

Total amount available to distribute

Latest Scenario

Equal Distribution

Equal Allocation Baseline · High confidence

Quick Start

Use this order if you are evaluating the demo for the first time.

Hub Goals

These goals define what counts as a good portfolio for this manager.

Advance earlier MND intervention by balancing target validation with earlier detection capability.
Prefer portfolios that produce decision-grade translational evidence rather than broad exploratory spend.

Target Milestones

The portfolio should be judged against these hub-level outcomes.

Validated MND target package
Biomarker panel and GP risk-score prototype
At least one synthetic comparator that stress-tests translational trade-offs

Projects By Stage

Funding Summary

Row Mix

Latest Scenario Snapshot

A quick plain-language read on the most recent saved strategy run.

Top Funded Project

MND STaR target validation programme

Budget Deployed

£180,000

Observed Public Funding Facts

£1.7M

Confidence High